Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

Rhee Hun Kang, Ma Li Wong, Myoung Jin Choi, Jong Woo Paik, Min-Soo Lee

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Modulations of serotonergic and noradrenergic systems are thought to be critical to the therapeutic effect of most antidepressants, and their efficacies have been shown to depend on a functional polymorphism within the promoter region of the serotonin transporter gene (5-HTTLPR). Mirtazapine has a dual-action profile, combining the enhancement of the noradrenergic neurotransmitter system with specific actions on particular serotonergic receptor subtypes. The goal of this study was to elucidate whether the 5-HTTLPR polymorphism is associated with the mirtazapine antidepressant response in subjects with major depressive disorder (MDD). One hundred and one MDD patients were evaluated during 4 weeks of mirtazapine treatment. The severity of depression was assessed with the 21-item Hamilton Depression Rating scale, and the 5-HTTLPR genotypes in the patients were determined using the polymerase chain reaction. Our results showed that responses at the 2nd and 4th  weeks were significantly better for the s/s genotype of the 5-HTTLPR polymorphism than for l-allele carriers. These results support our hypothesis that the response to noradrenergic and specific serotonergic antidepressants is significantly associated with the 5-HTTLPR polymorphism.

Original languageEnglish
Pages (from-to)1317-1321
Number of pages5
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume31
Issue number6
DOIs
Publication statusPublished - 2007 Aug 15

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Major Depressive Disorder
Antidepressive Agents
Genotype
Depression
Therapeutic Uses
Genetic Promoter Regions
Neurotransmitter Agents
Alleles
Polymerase Chain Reaction
Genes
mirtazapine
Therapeutics

Keywords

  • 5-HTTLPR
  • MDD
  • Mirtazapine

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder. / Kang, Rhee Hun; Wong, Ma Li; Choi, Myoung Jin; Paik, Jong Woo; Lee, Min-Soo.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, No. 6, 15.08.2007, p. 1317-1321.

Research output: Contribution to journalArticle

@article{b9baa63405d5471d90f69c2739647cf4,
title = "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder",
abstract = "Modulations of serotonergic and noradrenergic systems are thought to be critical to the therapeutic effect of most antidepressants, and their efficacies have been shown to depend on a functional polymorphism within the promoter region of the serotonin transporter gene (5-HTTLPR). Mirtazapine has a dual-action profile, combining the enhancement of the noradrenergic neurotransmitter system with specific actions on particular serotonergic receptor subtypes. The goal of this study was to elucidate whether the 5-HTTLPR polymorphism is associated with the mirtazapine antidepressant response in subjects with major depressive disorder (MDD). One hundred and one MDD patients were evaluated during 4 weeks of mirtazapine treatment. The severity of depression was assessed with the 21-item Hamilton Depression Rating scale, and the 5-HTTLPR genotypes in the patients were determined using the polymerase chain reaction. Our results showed that responses at the 2nd and 4th  weeks were significantly better for the s/s genotype of the 5-HTTLPR polymorphism than for l-allele carriers. These results support our hypothesis that the response to noradrenergic and specific serotonergic antidepressants is significantly associated with the 5-HTTLPR polymorphism.",
keywords = "5-HTTLPR, MDD, Mirtazapine",
author = "Kang, {Rhee Hun} and Wong, {Ma Li} and Choi, {Myoung Jin} and Paik, {Jong Woo} and Min-Soo Lee",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.pnpbp.2007.05.018",
language = "English",
volume = "31",
pages = "1317--1321",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

AU - Kang, Rhee Hun

AU - Wong, Ma Li

AU - Choi, Myoung Jin

AU - Paik, Jong Woo

AU - Lee, Min-Soo

PY - 2007/8/15

Y1 - 2007/8/15

N2 - Modulations of serotonergic and noradrenergic systems are thought to be critical to the therapeutic effect of most antidepressants, and their efficacies have been shown to depend on a functional polymorphism within the promoter region of the serotonin transporter gene (5-HTTLPR). Mirtazapine has a dual-action profile, combining the enhancement of the noradrenergic neurotransmitter system with specific actions on particular serotonergic receptor subtypes. The goal of this study was to elucidate whether the 5-HTTLPR polymorphism is associated with the mirtazapine antidepressant response in subjects with major depressive disorder (MDD). One hundred and one MDD patients were evaluated during 4 weeks of mirtazapine treatment. The severity of depression was assessed with the 21-item Hamilton Depression Rating scale, and the 5-HTTLPR genotypes in the patients were determined using the polymerase chain reaction. Our results showed that responses at the 2nd and 4th  weeks were significantly better for the s/s genotype of the 5-HTTLPR polymorphism than for l-allele carriers. These results support our hypothesis that the response to noradrenergic and specific serotonergic antidepressants is significantly associated with the 5-HTTLPR polymorphism.

AB - Modulations of serotonergic and noradrenergic systems are thought to be critical to the therapeutic effect of most antidepressants, and their efficacies have been shown to depend on a functional polymorphism within the promoter region of the serotonin transporter gene (5-HTTLPR). Mirtazapine has a dual-action profile, combining the enhancement of the noradrenergic neurotransmitter system with specific actions on particular serotonergic receptor subtypes. The goal of this study was to elucidate whether the 5-HTTLPR polymorphism is associated with the mirtazapine antidepressant response in subjects with major depressive disorder (MDD). One hundred and one MDD patients were evaluated during 4 weeks of mirtazapine treatment. The severity of depression was assessed with the 21-item Hamilton Depression Rating scale, and the 5-HTTLPR genotypes in the patients were determined using the polymerase chain reaction. Our results showed that responses at the 2nd and 4th  weeks were significantly better for the s/s genotype of the 5-HTTLPR polymorphism than for l-allele carriers. These results support our hypothesis that the response to noradrenergic and specific serotonergic antidepressants is significantly associated with the 5-HTTLPR polymorphism.

KW - 5-HTTLPR

KW - MDD

KW - Mirtazapine

UR - http://www.scopus.com/inward/record.url?scp=34447565937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447565937&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2007.05.018

DO - 10.1016/j.pnpbp.2007.05.018

M3 - Article

C2 - 17618721

AN - SCOPUS:34447565937

VL - 31

SP - 1317

EP - 1321

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 6

ER -